Net loss of Biogen Pharmachem Industries reported to Rs 1.00 crore in the quarter ended September 2024 as against net profit of Rs 0.72 crore during the previous quarter ended September 2023. There were no Sales reported in the quarter ended September 2024 and during the previous quarter ended September 2023.Powered by Capital Market - Live News

Biogen Pharmachem Industries will hold a meeting of the Board of Directors of the Company on 13 November 2024.Powered by Capital Market - Live News

Biogen Pharmachem Industries announced that the Annual General Meeting (AGM) of the company will be held on 28 September 2024.Powered by Capital Market - Live News

Biogen Pharmachem Industries announced that the Annual General Meeting (AGM) of the company will be held on 28 September 2024.Powered by Capital Market - Live News

Biogen Pharmachem Industries has revised the meeting of the Board of Directors which was scheduled to be held on 9 August 2024. The meeting will now be held on 13 August 2024.Powered by Capital Market - Live News